Dr. David Golombos, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,660 | 93 | 95.8% |
| Education | $116.70 | 4 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $566.93 | 33 | $0 (2023) |
| Edap Technomed Inc | $565.47 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $291.09 | 12 | $0 (2022) |
| UroGen Pharma, Inc. | $269.67 | 3 | $0 (2023) |
| KOELIS Inc. | $268.58 | 4 | $0 (2024) |
| Coloplast Corp | $186.90 | 13 | $0 (2022) |
| Photocure Inc | $119.51 | 1 | $0 (2019) |
| KARL STORZ Endoscopy-America | $117.19 | 2 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $77.35 | 5 | $0 (2022) |
| Myovant Sciences Inc. | $56.86 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $880.65 | 9 | Edap Technomed Inc ($524.00) |
| 2023 | $337.71 | 6 | UroGen Pharma, Inc. ($243.40) |
| 2022 | $586.86 | 27 | Astellas Pharma US Inc ($185.67) |
| 2021 | $216.88 | 14 | COLOPLAST CORP ($88.41) |
| 2020 | $148.40 | 9 | Astellas Pharma US Inc ($91.70) |
| 2019 | $399.05 | 20 | Astellas Pharma US Inc ($135.66) |
| 2018 | $191.09 | 11 | Astellas Pharma US Inc ($112.91) |
| 2017 | $15.87 | 1 | 180 Medical, Inc. ($15.87) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $78.00 | General |
| 12/04/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $78.00 | General |
| 07/31/2024 | KARL STORZ Endoscopy-America | HOPKINS (Device) | Food and Beverage | In-kind items and services | $99.96 | General |
| Category: LAPAROSCOPY | ||||||
| 07/31/2024 | KARL STORZ Endoscopy-America | HOPKINS (Device) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: LAPAROSCOPY | ||||||
| 05/20/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $184.00 | General |
| 05/20/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $184.00 | General |
| 03/07/2024 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $71.19 | General |
| Category: Urology | ||||||
| 03/04/2024 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $144.43 | General |
| Category: Urology | ||||||
| 03/04/2024 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Urology | ||||||
| 11/29/2023 | EDAP TECHNOMED INC | — | Food and Beverage | Cash or cash equivalent | $41.47 | General |
| 10/17/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: SURGERY | ||||||
| 05/17/2023 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Urology | ||||||
| 04/28/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $129.44 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/05/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: UROTHELIAL CANCER | ||||||
| 01/18/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Urology | ||||||
| 12/06/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Urology | ||||||
| 11/07/2022 | DENTSPLY IH Inc. | LoFric (Device) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Medical Urology | ||||||
| 10/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Oncology | ||||||
| 10/18/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Urology | ||||||
| 10/04/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Oncology | ||||||
| 09/27/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Urology | ||||||
| 09/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Oncology | ||||||
| 09/13/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 08/18/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Urology | ||||||
| 08/16/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: UROTHELIAL CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 181 | 193 | $138,550 | $13,471 |
| 2022 | 12 | 693 | 861 | $379,926 | $94,047 |
| 2021 | 14 | 745 | 942 | $492,219 | $118,288 |
| 2020 | 11 | 587 | 726 | $302,227 | $65,739 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 19 | 19 | $27,748 | $3,009 | 10.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 24 | 24 | $38,955 | $2,513 | 6.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $18,749 | $1,811 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 22 | $18,771 | $1,790 | 9.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 30 | $10,800 | $1,756 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 31 | $8,060 | $1,002 | 12.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 13 | $7,902 | $692.40 | 8.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 23 | 23 | $5,594 | $596.46 | 10.7% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 11 | 14 | $1,971 | $300.11 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 301 | $108,360 | $33,813 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 207 | $53,820 | $16,560 | 30.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 39 | 52 | $40,092 | $12,732 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $28,035 | $9,443 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 40 | $19,100 | $6,442 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $17,516 | $5,739 | 32.8% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 33 | 33 | $28,776 | $3,840 | 13.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 19 | 34 | $26,214 | $2,406 | 9.2% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 11 | 12 | $37,500 | $1,396 | 3.7% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 32 | 32 | $8,000 | $811.80 | 10.1% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 15 | 18 | $1,098 | $386.90 | 35.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 23 | 27 | $8,100 | $295.63 | 3.6% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 12 | 13 | $3,315 | $180.71 | 5.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 211 | 317 | $100,780 | $37,621 | 37.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 168 | 223 | $57,980 | $18,081 | 31.2% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2021 | 13 | 13 | $75,569 | $18,048 | 23.9% |
About Dr. David Golombos, M.D
Dr. David Golombos, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1649591777.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Golombos, M.D has received a total of $2,777 in payments from pharmaceutical and medical device companies, with $880.65 received in 2024. These payments were reported across 97 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,660).
As a Medicare-enrolled provider, Golombos has provided services to 2,206 Medicare beneficiaries, totaling 2,722 services with total Medicare billing of $291,545. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Urology
- Location Stony Brook, NY
- Active Since 06/11/2010
- Last Updated 03/17/2018
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649591777
Products in Payments
- XTANDI (Drug) $302.70
- JELMYTO (Drug) $269.67
- Trinity (Device) $268.58
- ERLEADA (Drug) $164.46
- Myrbetriq (Drug) $160.83
- SpeediCath (Device) $131.06
- Erleada (Drug) $126.63
- Cysview (Drug) $119.51
- HOPKINS (Device) $117.19
- Prolaris (Device) $77.35
- MYRBETRIQ (Drug) $75.08
- ORGOVYX (Drug) $56.86
- Nubeqa (Drug) $54.42
- OXLUMO (Drug) $31.18
- LoFric (Device) $30.30
- ELIGARD (Drug) $29.66
- CONTINENCE CARE (Device) $28.36
- SPEEDICATH (Device) $27.48
- Axumin (Drug) $20.79
- (815) Thiola (Drug) $16.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Stony Brook
Noreen Bukhari-Parlakturk, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $26,258
Aadit Shah, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $18,802
Kristine Jang, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $18,437
Mr. Stuart Drew
Student in an Organized Health Care Education/Training Program — Payments: $10,662
Dr. Brian Mccormack, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $9,541
Sonya Marcus, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $8,616